# L_2012179EN.01000301.xml

| 11.7.2012 | EN | Official Journal of the European Union | L 179/3 |
| --- | --- | --- | --- |

11.7.2012

EN

Official Journal of the European Union

L 179/3

---

COMMISSION REGULATION (EU) No 618/2012

of 10 July 2012

amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (1), and in particular Article 37(5) thereof,

Whereas:

| (1) | Part 3 of Annex VI to Regulation (EC) No 1272/2008 contains two lists of harmonised classification and labelling of hazardous substances. Table 3.1 lists the harmonised classification and labelling of hazardous substances based on the criteria set out in Parts 2 to 5 of Annex I to Regulation (EC) No 1272/2008. Table 3.2 lists the harmonised classification and labelling of hazardous substances based on the criteria set out in Annex VI to Council Directive 67/548/EEC of 27 June 1967 on the approximation of laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances (2). Those two lists need to be amended to include updated classifications for substances already subject to those harmonised classifications and to include new harmonised classifications. |
| --- | --- |

(1)

Part 3 of Annex VI to Regulation (EC) No 1272/2008 contains two lists of harmonised classification and labelling of hazardous substances. Table 3.1 lists the harmonised classification and labelling of hazardous substances based on the criteria set out in Parts 2 to 5 of Annex I to Regulation (EC) No 1272/2008. Table 3.2 lists the harmonised classification and labelling of hazardous substances based on the criteria set out in Annex VI to Council Directive 67/548/EEC of 27 June 1967 on the approximation of laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances (2). Those two lists need to be amended to include updated classifications for substances already subject to those harmonised classifications and to include new harmonised classifications.

| (2) | The Committee for Risk Assessment of the European Chemicals Agency (ECHA) has issued opinions on proposals for harmonised classification and labelling of substances which had been submitted to ECHA pursuant to Article 37 of Regulation (EC) No 1272/2008. Based on those opinions, as well as on the comments received from the parties concerned, it is appropriate to amend Annex VI to Regulation (EC) No 1272/2008 in order to harmonise the classification and labelling of certain substances. |
| --- | --- |

(2)

The Committee for Risk Assessment of the European Chemicals Agency (ECHA) has issued opinions on proposals for harmonised classification and labelling of substances which had been submitted to ECHA pursuant to Article 37 of Regulation (EC) No 1272/2008. Based on those opinions, as well as on the comments received from the parties concerned, it is appropriate to amend Annex VI to Regulation (EC) No 1272/2008 in order to harmonise the classification and labelling of certain substances.

| (3) | The harmonised classifications set out in Part 3 of Annex VI to Regulation (EC) No 1272/2008, as amended by this Regulation, should not apply immediately, as a certain period of time will be necessary to allow operators to adapt the labelling and packaging of substances and mixtures to the new classifications and to sell existing stocks. In addition, a certain period of time will be necessary to allow operators to comply with the registration obligations resulting from the new harmonised classifications for substances classified as carcinogenic, mutagenic or toxic to reproduction, categories 1A and 1B (Table 3.1) and categories 1 and 2 (Table 3.2), or as very toxic to aquatic organisms which may cause long term effects in the aquatic environment, in particular with those set out in Article 23 of Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC (3). |
| --- | --- |

(3)

The harmonised classifications set out in Part 3 of Annex VI to Regulation (EC) No 1272/2008, as amended by this Regulation, should not apply immediately, as a certain period of time will be necessary to allow operators to adapt the labelling and packaging of substances and mixtures to the new classifications and to sell existing stocks. In addition, a certain period of time will be necessary to allow operators to comply with the registration obligations resulting from the new harmonised classifications for substances classified as carcinogenic, mutagenic or toxic to reproduction, categories 1A and 1B (Table 3.1) and categories 1 and 2 (Table 3.2), or as very toxic to aquatic organisms which may cause long term effects in the aquatic environment, in particular with those set out in Article 23 of Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC (3).

| (4) | In line with the transitional provisions of Regulation (EC) No 1272/2008 which allow the application of the new provisions at an earlier stage on a voluntary basis, suppliers should have the possibility of applying the harmonised classifications set out in Part 3 of Annex VI to Regulation (EC) No 1272/2008, as amended by this Regulation, and of adapting the labelling and packaging accordingly on a voluntary basis before 1 December 2013. |
| --- | --- |

(4)

In line with the transitional provisions of Regulation (EC) No 1272/2008 which allow the application of the new provisions at an earlier stage on a voluntary basis, suppliers should have the possibility of applying the harmonised classifications set out in Part 3 of Annex VI to Regulation (EC) No 1272/2008, as amended by this Regulation, and of adapting the labelling and packaging accordingly on a voluntary basis before 1 December 2013.

| (5) | The measures provided for in this Regulation are in accordance with the opinion of the Committee established under Article 133 of Regulation (EC) No 1907/2006, |
| --- | --- |

(5)

The measures provided for in this Regulation are in accordance with the opinion of the Committee established under Article 133 of Regulation (EC) No 1907/2006,

HAS ADOPTED THIS REGULATION:

Article 1

Part 3 of Annex VI to Regulation (EC) No 1272/2008 is amended as follows:

| (1) | Table 3.1 is amended as follows:






  (a) | The entries corresponding to the entries set out in Annex I are replaced by the entries set out in that Annex; |
| --- | --- | --- |

(1)

Table 3.1 is amended as follows:

(a)

The entries corresponding to the entries set out in Annex I are replaced by the entries set out in that Annex;

| (b) | The entries set out in Annex II are inserted in accordance with the order of the entries set out in Table 3.1. |
| --- | --- |

(b)

The entries set out in Annex II are inserted in accordance with the order of the entries set out in Table 3.1.

| (2) | Table 3.2 is amended as follows:






  (a) | The entries corresponding to the entries set out in Annex III are replaced by the entries set out in that Annex; |
| --- | --- | --- |

(2)

Table 3.2 is amended as follows:

(a)

The entries corresponding to the entries set out in Annex III are replaced by the entries set out in that Annex;

| (b) | The entries set out in Annex IV are inserted in accordance with the order of the entries set out in Table 3.2. |
| --- | --- |

(b)

The entries set out in Annex IV are inserted in accordance with the order of the entries set out in Table 3.2.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

Article 1 shall apply from 1 December 2013.

The harmonised classifications set out in Part 3 of Annex VI to Regulation (EC) No 1272/2008, as amended by this Regulation, may be applied before 1 December 2013.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 10 July 2012.

For the Commission

The President

José Manuel BARROSO

---

(1)  
  OJ L 353, 31.12.2008, p. 1.

1

(2)  
  OJ 196, 16.8.1967, p. 1.

2

(3)  
  OJ L 136, 29.5.2007, p. 3.

3

---

ANNEX I

| Index No | International Chemical Identification | EC No | CAS No | Classification | Labelling | Specific Conc. Limits, M-factors | Notes |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Hazard Class and Category Code(s) | Hazard Statement Code(s) | Pictogram, Signal Word Code(s) | Hazard statement Code(s) | Suppl. Hazard statement Code(s) |
| "009-016-00-2 | trisodium hexafluoroaluminate [1] | 237-410-6 [1] | 13775-53-6 [1] | STOT RE 1
  Acute Tox. 4
  Aquatic Chronic 2 | H372
  H332
  H411 | GHS07
  GHS08
  GHS09
  Dgr | H372
  H332
  H411 | | | |
| trisodium hexafluoroaluminate (cryolite) [2] | 239-148-8 [2] | 15096-52-3 [2] |
| 603-012-00-X | 2-ethoxyethanol;
  ethylene glycol monoethyl ether | 203-804-1 | 110-80-5 | Flam. Liq. 3
  Repr. 1B
  Acute Tox. 3
  Acute Tox. 4 | H226
  H360FD
  H331
  H302 | GHS02
  GHS08
  GHS06
  Dgr | H226
  H360FD
  H331
  H302 | | | |
| 603-025-00-0 | tetrahydrofuran | 203-726-8 | 109-99-9 | Flam. Liq. 2
  Carc. 2
  Eye Irrit. 2
  STOT SE 3 | H225
  H351
  H319
  H335 | GHS02
  GHS07
  GHS08
  Dgr | H225
  H351
  H319
  H335 | EUH019 | STOT SE 3;
  H335: C ≥ 25 %
  Eye Irrit.2;
  H319: C ≥ 25 % | |
| 613-016-00-3 | fuberidazole (ISO);
  2-(2-furyl)-1H-benzimidazole | 223-404-0 | 3878-19-1 | Carc. 2
  Acute Tox. 4
  STOT RE 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H302
  H373 (heart)
  H317
  H400
  H410 | GHS07
  GHS08
  GHS09
  Wng | H351
  H302
  H373 (heart)
  H317
  H410 | | M = 1 | |
| 617-001-00-2 | di-tert-butyl peroxide | 203-733-6 | 110-05-4 | Org. Perox. E
  Flam. Liq. 2
  Muta. 2 | H242
  H225
  H341 | GHS02
  GHS08
  Dgr | H242
  H225
  H341" | | | |

Index No

International Chemical Identification

EC No

CAS No

Classification

Labelling

Specific Conc. Limits, M-factors

Notes

Hazard Class and Category Code(s)

Hazard Statement Code(s)

Pictogram, Signal Word Code(s)

Hazard statement Code(s)

Suppl. Hazard statement Code(s)

"009-016-00-2

trisodium hexafluoroaluminate [1]

237-410-6 [1]

13775-53-6 [1]

STOT RE 1

Acute Tox. 4

Aquatic Chronic 2

H372

H332

H411

GHS07

GHS08

GHS09

Dgr

H372

H332

H411

trisodium hexafluoroaluminate (cryolite) [2]

239-148-8 [2]

15096-52-3 [2]

603-012-00-X

2-ethoxyethanol;

ethylene glycol monoethyl ether

203-804-1

110-80-5

Flam. Liq. 3

Repr. 1B

Acute Tox. 3

Acute Tox. 4

H226

H360FD

H331

H302

GHS02

GHS08

GHS06

Dgr

H226

H360FD

H331

H302

603-025-00-0

tetrahydrofuran

203-726-8

109-99-9

Flam. Liq. 2

Carc. 2

Eye Irrit. 2

STOT SE 3

H225

H351

H319

H335

GHS02

GHS07

GHS08

Dgr

H225

H351

H319

H335

EUH019

STOT SE 3;

H335: C ≥ 25 %

Eye Irrit.2;

H319: C ≥ 25 %

613-016-00-3

fuberidazole (ISO);

2-(2-furyl)-1H-benzimidazole

223-404-0

3878-19-1

Carc. 2

Acute Tox. 4

STOT RE 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H351

H302

H373 (heart)

H317

H400

H410

GHS07

GHS08

GHS09

Wng

H351

H302

H373 (heart)

H317

H410

M = 1

617-001-00-2

di-tert-butyl peroxide

203-733-6

110-05-4

Org. Perox. E

Flam. Liq. 2

Muta. 2

H242

H225

H341

GHS02

GHS08

Dgr

H242

H225

H341"

---

ANNEX II

| Index No | International Chemical Identification | EC No | CAS No | Classification | Labelling | Specific Conc. Limits, M-factors | Notes |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Hazard Class and Category Code(s) | Hazard Statement Code(s) | Pictogram, Signal Word Code(s) | Hazard statement Code(s) | Suppl. Hazard statement Code(s) |
| ‘015-199-00-X | tris[2-chloro-1-chloromethyl)ethyl] phosphate | 237-159-2 | 13674-87-8 | Carc. 2 | H351 | GSH08
  Wng | H351 | | | |
| 015-200-00-3 | indium phosphide | 244-959-5 | 22398-80-7 | Carc. 1B
  Repr. 2
  STOT RE 1 | H350
  H361f
  H372 (lungs) | GHS08
  Dgr | H350
  H361f
  H372 (lungs) | | STOT RE 1;
  H372: C ≥0,1 %
  Carc 1B;
  H350: C ≥0,01 %
  STOT RE 2;
  H373: 0,01 % ≤ C < 0,1 % | |
| 015-201-00-9 | trixylyl phosphate | 246-677-8 | 25155-23-1 | Repr. 1B | H360F | GHS08
  Dgr | H360F | | | |
| 015-202-00-4 | tris(nonylphenyl) phosphite | 247-759-6 | 26523-78-4 | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | | |
| 015-203-00-X | diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide | 278-355-8 | 75980-60-8 | Repr. 2 | H361f (causing atrophy of the testes) | GHS08
  Wng | H361f (causing atrophy of the testes) | | | |
| 602-109-00-4 | Hexabromocyclododecane [1] | 247-148-4 [1] | 25637-99-4[1] | Repr. 2
  Lact. | H361
  H362 | GHS08
  Wng | H361
  H362 | | | |
| 1,2,5,6,9,10-hexabromocyclododecane [2] | 221-695-9[2] | 3194-55-6[2] |
| 606-143-00-0 | abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1] | _ [1] | 71751-41-2 [1] | Repr. 2
  Acute Tox. 2
  Acute Tox. 1
  STOT RE 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H361d
  H300
  H330
  H372 (nervous system)
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H361d
  H300
  H330
  H372 (nervous system)
  H410 | | STOT RE 1;
  H372: C ≥ 5 %
  STOT RE 2;
  H373: 0,5 % ≤C<5 %
  M = 10 000 | |
| avermectin B1a (purity ≥80 %); [2] | 265-610-3 [2] | 65195-55-3 [2] |
| 606-144-00-6 | acequinocyl (ISO);
  3-dodecyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl acetate | — | 57960-19-7 | Skin Sens. 1
  STOT SE 1
  STOT RE 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H370 (lung)
  (inhalation)
  H373 (blood system)
  H400
  H410 | GHS07
  GHS08
  GHS09
  Dgr | H317
  H370 (lung)
  (inhalation)
  H373 (blood system)
  H410 | | M = 1 000 | |
| 607-698-00-1 | 4-tert-butylbenzoic acid | 202-696-3 | 98-73-7 | Repr. 1B
  STOT RE 1
  Acute Tox. 4 | H360F
  H372
  H302 | GHS07
  GHS08
  Dgr | H360F
  H372
  H302 | | | |
| 612-281-00-2 | leucomalachite green;
  N,N,N',N'-tetramethyl-4,4'-benzylidenedianiline | 204-961-9 | 129-73-7 | Carc. 2
  Muta. 2 | H351
  H341 | GHS08
  Wng | H351
  H341 | | | |
| 616-205-00-9 | Metazachlor (ISO);
  2-chloro-N-(2,6-dimethylphenyl)-N-(1H-pyrazol-1-ylmethyl)acetamide | 266-583-0 | 67129-08-2 | Skin Sens. 1B
  Carc. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H351
  H400
  H410 | GHS07
  GHS08
  GHS09
  Wng | H317
  H351
  H410 | | M = 100
  M = 100’ | |

Index No

International Chemical Identification

EC No

CAS No

Classification

Labelling

Specific Conc. Limits, M-factors

Notes

Hazard Class and Category Code(s)

Hazard Statement Code(s)

Pictogram, Signal Word Code(s)

Hazard statement Code(s)

Suppl. Hazard statement Code(s)

‘015-199-00-X

tris[2-chloro-1-chloromethyl)ethyl] phosphate

237-159-2

13674-87-8

Carc. 2

H351

GSH08

Wng

H351

015-200-00-3

indium phosphide

244-959-5

22398-80-7

Carc. 1B

Repr. 2

STOT RE 1

H350

H361f

H372 (lungs)

GHS08

Dgr

H350

H361f

H372 (lungs)

STOT RE 1;

H372: C ≥0,1 %

Carc 1B;

H350: C ≥0,01 %

STOT RE 2;

H373: 0,01 % ≤ C < 0,1 %

015-201-00-9

trixylyl phosphate

246-677-8

25155-23-1

Repr. 1B

H360F

GHS08

Dgr

H360F

015-202-00-4

tris(nonylphenyl) phosphite

247-759-6

26523-78-4

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

015-203-00-X

diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide

278-355-8

75980-60-8

Repr. 2

H361f (causing atrophy of the testes)

GHS08

Wng

H361f (causing atrophy of the testes)

602-109-00-4

Hexabromocyclododecane [1]

247-148-4 [1]

25637-99-4[1]

Repr. 2

Lact.

H361

H362

GHS08

Wng

H361

H362

1,2,5,6,9,10-hexabromocyclododecane [2]

221-695-9[2]

3194-55-6[2]

606-143-00-0

abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1]

_ [1]

71751-41-2 [1]

Repr. 2

Acute Tox. 2

Acute Tox. 1

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1

H361d

H300

H330

H372 (nervous system)

H400

H410

GHS06

GHS08

GHS09

Dgr

H361d

H300

H330

H372 (nervous system)

H410

STOT RE 1;

H372: C ≥ 5 %

STOT RE 2;

H373: 0,5 % ≤C<5 %

M = 10 000

avermectin B1a (purity ≥80 %); [2]

265-610-3 [2]

65195-55-3 [2]

606-144-00-6

acequinocyl (ISO);

3-dodecyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl acetate

—

57960-19-7

Skin Sens. 1

STOT SE 1

STOT RE 2

Aquatic Acute 1

Aquatic Chronic 1

H317

H370 (lung)

(inhalation)

H373 (blood system)

H400

H410

GHS07

GHS08

GHS09

Dgr

H317

H370 (lung)

(inhalation)

H373 (blood system)

H410

M = 1 000

607-698-00-1

4-tert-butylbenzoic acid

202-696-3

98-73-7

Repr. 1B

STOT RE 1

Acute Tox. 4

H360F

H372

H302

GHS07

GHS08

Dgr

H360F

H372

H302

612-281-00-2

leucomalachite green;

N,N,N',N'-tetramethyl-4,4'-benzylidenedianiline

204-961-9

129-73-7

Carc. 2

Muta. 2

H351

H341

GHS08

Wng

H351

H341

616-205-00-9

Metazachlor (ISO);

2-chloro-N-(2,6-dimethylphenyl)-N-(1H-pyrazol-1-ylmethyl)acetamide

266-583-0

67129-08-2

Skin Sens. 1B

Carc. 2

Aquatic Acute 1

Aquatic Chronic 1

H317

H351

H400

H410

GHS07

GHS08

GHS09

Wng

H317

H351

H410

M = 100

M = 100’

---

ANNEX III

| Index No | International Chemical Identification | EC No | CAS No | Classification | Labelling | Concentration Limits | Notes |
| --- | --- | --- | --- | --- | --- | --- | --- |
| "009-016-00-2 | trisodium hexafluoroaluminate [1] | 237-410-6 [1] | 13775-53-6 [1] | Xn; R20
  T; R48/23/25
  N; R51-53 | T; N
  R: 20-48/23/25-51/53
  S: (1/2-)22-37-45-61 | | |
| trisodium hexafluoroaluminate (cryolite) [2] | 239-148-8 [2] | 15096-52-3 [2] |
| 603-012-00-X | 2-ethoxyethanol;
  ethylene glycol monoethyl ether | 203-804-1 | 110-80-5 | R10
  Repr. Cat. 2; R60-61
  Xn; R20/22 | T
  R: 60-61-10-20/22
  S: 53-45 | | E |
| 603-025-00-0 | tetrahydrofuran | 203-726-8 | 109-99-9 | F; R11-19
  Carc. Cat. 3; R40
  Xi; R36/37 | F; Xn
  R: 11-19-40-36/37
  S: (2-)(13-)16-29-33-36-37(-46) | Xi; R36/37: C ≥ 25 % | |
| 613-016-00-3 | fuberidazole (ISO);
  2-(2-furyl)-1H-benzimidazole | 223-404-0 | 3878-19-1 | Carc. Cat. 3; R40
  Xn; R48/22
  Xn; R22
  Xi; R43
  N; R50-53 | Xn; N
  R: 40-48/22-22-43-50/53
  S: (2)-22-36/37-60-61 | N; R50-53: C ≥ 25 %
  N; R51-53: 2,5 % ≤ C < 25 %
  R52-53: 0,25 % ≤ C < 2,5 % | |
| 617-001-00-2 | di-tert-butyl peroxide | 203-733-6 | 110-05-4 | O; R7
  F; R11
  Muta. Cat. 3, R68 | O; F; Xn
  R: 7-11-68
  S: (2-)3/7-14-16-23-36/37/39" | | |

Index No

International Chemical Identification

EC No

CAS No

Classification

Labelling

Concentration Limits

Notes

"009-016-00-2

trisodium hexafluoroaluminate [1]

237-410-6 [1]

13775-53-6 [1]

Xn; R20

T; R48/23/25

N; R51-53

T; N

R: 20-48/23/25-51/53

S: (1/2-)22-37-45-61

trisodium hexafluoroaluminate (cryolite) [2]

239-148-8 [2]

15096-52-3 [2]

603-012-00-X

2-ethoxyethanol;

ethylene glycol monoethyl ether

203-804-1

110-80-5

R10

Repr. Cat. 2; R60-61

Xn; R20/22

T

R: 60-61-10-20/22

S: 53-45

E

603-025-00-0

tetrahydrofuran

203-726-8

109-99-9

F; R11-19

Carc. Cat. 3; R40

Xi; R36/37

F; Xn

R: 11-19-40-36/37

S: (2-)(13-)16-29-33-36-37(-46)

Xi; R36/37: C ≥ 25 %

613-016-00-3

fuberidazole (ISO);

2-(2-furyl)-1H-benzimidazole

223-404-0

3878-19-1

Carc. Cat. 3; R40

Xn; R48/22

Xn; R22

Xi; R43

N; R50-53

Xn; N

R: 40-48/22-22-43-50/53

S: (2)-22-36/37-60-61

N; R50-53: C ≥ 25 %

N; R51-53: 2,5 % ≤ C < 25 %

R52-53: 0,25 % ≤ C < 2,5 %

617-001-00-2

di-tert-butyl peroxide

203-733-6

110-05-4

O; R7

F; R11

Muta. Cat. 3, R68

O; F; Xn

R: 7-11-68

S: (2-)3/7-14-16-23-36/37/39"

---

ANNEX IV

| Index No | International Chemical Identification | EC No | CAS No | Classification | Labelling | Concentration Limits | Notes |
| --- | --- | --- | --- | --- | --- | --- | --- |
| ‘015-199-00-X | tris[2-chloro-1-chloromethyl)ethyl] phosphate | 237-159-2 | 13674-87-8 | Carc. Cat. 3; R40 | Xn
  R: 40
  S: (2-)36/37 | | |
| 015-200-00-3 | indium phosphide | 244-959-5 | 22398-80-7 | Carc. Cat. 2; R45
  Repr. Cat. 3; R62
  T; R48/23 | T
  R: 45–48/23–62
  S: 45- 53 | T; R48/23: C ≥0,1%
  Carc Cat 2; R45: C ≥0,01%
  Xn; R48/20: 0,01%≤ C < 0,1% | E |
| 015-201-00-9 | trixylyl phosphate | 246-677-8 | 25155-23-1 | Repr. Cat. 2; R60 | T
  R: 60
  S: 53-45 | | |
| 015-202-00-4 | tris(nonylphenyl) phosphite | 247-759-6 | 26523-78-4 | Xi; R43
  N; R50-53 | Xi; N
  R: 43-50/53
  S: 24-37-60-61 | | |
| 015-203-00-X | diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide | 278-355-8 | 75980-60-8 | Repr. Cat. 3; R62 | Xn
  R: 62
  S: (2)-22-36/37. | | |
| 602-109-00-4 | Hexabromocyclododecane [1] | 247-148-4 [1] | 25637-99-4[1] | Repr. Cat. 3; R63 R64 | Xn
  R: 63-64
  S: 36/37-53 | | |
| 1,2,5,6,9,10-hexabromocyclododecane [2] | 221-695-9[2] | 3194-55-6[2] |
| 606-143-00-0 | abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1] | _ [1] | 71751-41-2 [1] | Repr. Cat. 3; R63
  T+; R26/28
  T; R48/23/25
  N; R50-53 | T+; N
  R: 63-26/28-48/23/25-50/53
  S: 28-36/37-45-60-61 | T; R48/23: C ≥ 5%
  Xn; R48/20: 0,5% ≤ C <5%
  N; R50-53: C ≥ 0,0025%
  N; R51-53: 0,00025% ≤ C <0,0025%
  R52-53: 0,000025% ≤ C<0,00025% | |
| avermectin B1a (purity ≥80%); [2] | 265-610-3 [2] | 65195-55-3 [2] |
| 606-144-00-6 | acequinocyl (ISO);
  3-dodecyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl acetate | — | 57960-19-7 | T; R39/23
  Xi; R43
  N; R50-53 | T; N
  R: 39/23-43-50/53,
  S: (2-)24-37-38-60-61 | N; R50-53: C ≥ 0,025%
  N; R51-53: 0,0025% ≤ C < 0,025%
  R52-53: 0,00025% ≤ C < 0,0025% | |
| 607-698-00-1 | 4-tert-butylbenzoic acid | 202-696-3 | 98-73-7 | Repr. Cat. 2; R60
  T; R48/23/24/25
  Xn; R22 | T
  R: 60-22-48/23/24/25
  S: 53-45 | | E |
| 612-281-00-2 | leucomalachite green
  N,N,N',N'-tetramethyl-4,4'-benzylidenedianiline | 204-961-9 | 129-73-7 | Carc. Cat. 3; R40
  Muta. Cat. 3; R68 | Xn
  R: 40-68
  S: (2-)36/37 | | |
| 616-205-00-9 | Metazachlor (ISO);
  2-chloro-N-(2,6-dimethylphenyl)-N-(1H-pyrazol-1-ylmethyl)acetamide | 266-583-0 | 67129-08-2 | R43
  Carc. Cat. 3; R40
  N; R50-53 | Xn; N
  R: 40-43-50/53
  S: (2-)36-37-60-61 | N; R50-53: C ≥ 0,25%
  N; R51-53: 0,025% ≤ C < 0,25%
  R52-53: 0,0025% ≤ C < 0,025%’ | |

Index No

International Chemical Identification

EC No

CAS No

Classification

Labelling

Concentration Limits

Notes

‘015-199-00-X

tris[2-chloro-1-chloromethyl)ethyl] phosphate

237-159-2

13674-87-8

Carc. Cat. 3; R40

Xn

R: 40

S: (2-)36/37

015-200-00-3

indium phosphide

244-959-5

22398-80-7

Carc. Cat. 2; R45

Repr. Cat. 3; R62

T; R48/23

T

R: 45–48/23–62

S: 45- 53

T; R48/23: C ≥0,1%

Carc Cat 2; R45: C ≥0,01%

Xn; R48/20: 0,01%≤ C < 0,1%

E

015-201-00-9

trixylyl phosphate

246-677-8

25155-23-1

Repr. Cat. 2; R60

T

R: 60

S: 53-45

015-202-00-4

tris(nonylphenyl) phosphite

247-759-6

26523-78-4

Xi; R43

N; R50-53

Xi; N

R: 43-50/53

S: 24-37-60-61

015-203-00-X

diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide

278-355-8

75980-60-8

Repr. Cat. 3; R62

Xn

R: 62

S: (2)-22-36/37.

602-109-00-4

Hexabromocyclododecane [1]

247-148-4 [1]

25637-99-4[1]

Repr. Cat. 3; R63 R64

Xn

R: 63-64

S: 36/37-53

1,2,5,6,9,10-hexabromocyclododecane [2]

221-695-9[2]

3194-55-6[2]

606-143-00-0

abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1]

_ [1]

71751-41-2 [1]

Repr. Cat. 3; R63

T+; R26/28

T; R48/23/25

N; R50-53

T+; N

R: 63-26/28-48/23/25-50/53

S: 28-36/37-45-60-61

T; R48/23: C ≥ 5%

Xn; R48/20: 0,5% ≤ C <5%

N; R50-53: C ≥ 0,0025%

N; R51-53: 0,00025% ≤ C <0,0025%

R52-53: 0,000025% ≤ C<0,00025%

avermectin B1a (purity ≥80%); [2]

265-610-3 [2]

65195-55-3 [2]

606-144-00-6

acequinocyl (ISO);

3-dodecyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl acetate

—

57960-19-7

T; R39/23

Xi; R43

N; R50-53

T; N

R: 39/23-43-50/53,

S: (2-)24-37-38-60-61

N; R50-53: C ≥ 0,025%

N; R51-53: 0,0025% ≤ C < 0,025%

R52-53: 0,00025% ≤ C < 0,0025%

607-698-00-1

4-tert-butylbenzoic acid

202-696-3

98-73-7

Repr. Cat. 2; R60

T; R48/23/24/25

Xn; R22

T

R: 60-22-48/23/24/25

S: 53-45

E

612-281-00-2

leucomalachite green

N,N,N',N'-tetramethyl-4,4'-benzylidenedianiline

204-961-9

129-73-7

Carc. Cat. 3; R40

Muta. Cat. 3; R68

Xn

R: 40-68

S: (2-)36/37

616-205-00-9

Metazachlor (ISO);

2-chloro-N-(2,6-dimethylphenyl)-N-(1H-pyrazol-1-ylmethyl)acetamide

266-583-0

67129-08-2

R43

Carc. Cat. 3; R40

N; R50-53

Xn; N

R: 40-43-50/53

S: (2-)36-37-60-61

N; R50-53: C ≥ 0,25%

N; R51-53: 0,025% ≤ C < 0,25%

R52-53: 0,0025% ≤ C < 0,025%’

---